Skip to main content

Table 1 Clinical characteristics of patients with and without carotid artery calcification

From: Fibroblast growth factor 23 is associated with carotid artery calcification in chronic kidney disease patients not undergoing dialysis: a cross-sectional study

 

All (n = 195)

CAAC (+) (n = 128)

CAAC (−) (n = 67)

p values

Age

68.8 ± 11.3

71.9 ± 9.4

62.7 ± 12.3

<0.01

Male

129 (66)

91 (71)

38 (57)

0.046

Hypertension

171 (88)

120 (94)

51 (76)

<0.01

Diabetes mellitus

92 (47)

72 (56)

20 (30)

<0.01

Smoking

110 (56)

82 (64)

28 (42)

<0.01

Dyslipidemia

146 (75)

102 (80)

44 (66)

0.03

Body mass index (kg/m2)

22.5 ± 4.5

22.3 ± 4.4

22.8 ± 4.6

0.45

Proteinuria (g/day)

1.2 (0.3-3.3)

1.8 (0.3-3.6)

0.9 (0.3-1.9)

0.06

C-reactive protein (mg/dL)

0.09 (0.04-0.22)

0.09 (0.04-0.24)

0.09 (0.03-0.19)

0.22

Hemoglobin (g/dL)

10.7 ± 2.1

10.3 ± 2.0

11.4 ± 2.2

<0.01

eGFR (ml/min/1.73m2)

23.2 (14.5-43.8)

20.0 (13.7-37.2)

34.3 (17.5-60.2)

<0.01

Serum corrected calcium (mg/dL)

9.4 ± 0.5

9.5 ± 0.6

9.3 ± 0.5

0.14

Serum phosphorus (mg/dL)

3.7 ± 0.7

3.8 ± 0.8

3.7 ± 0.7

0.80

Ca-P product (mg2/dL2)

35.3 ± 7.0

35.6 ± 7.2

34.6 ± 6.7

0.73

PTH (pg/mL)

73 (45–117)

82 (46–125)

56 (40–88)

0.03

1,25(OH)2Vitamin D (pg/mL)

25 (17–40)

24 (15–36)

30 (22–46)

<0.01

FGF23 (pg/mL)

64 (41–105)

73 (48–123)

50 (36–69)

<0.01

  1. Values are expressed as the means ± SD, number (percent), or median (interquartile range).
  2. CAAC carotid artery calcification, eGFR estimated glomerular filtration rate, Ca-P calcium-phosphorus, PTH parathyroid hormone, FGF fibroblast growth factor.